For topical applications Some users reconstitute GHK-Cu for topical rather than injectable use
Peptides may retain only 70-85% potency
Oral Wegovy is the first pill in its class approved by the FDA for long-term weight management, not just for diabetes
According to the company, it "is designed to mimic many of the physiological effects of fasting improved insulin sensitivity, reduced fat mass and more efficient energy metabolism without requiring significant changes in feeding routines or disrupting the human-animal bond that often centers around food." It has the potential to improve a cat's quality of life and support healthy aging
The GIPR pathway activation in tirzepatide enhances glucose control and energy expenditure, potentially allowing faster weight loss and metabolic stabilization
We believe in a patient-centric approach, focusing on open communication, safety, and comfort